Medical Care

Global Adenomyosis Treatment Market Research Report 2024

Adenomyosis disorder also known as Endometriosis interna, Adenomyosis uteri, Endometriosis uterine, or Adenomyometritis. Adenomyosis disorder occurs when endometrial tissue of the uterus endometrial cavity to grow into the uterus muscle that damage the uterine wall the uterine wall grow thicker.
The global Adenomyosis Treatment market was valued at US$ 222 million in 2023 and is anticipated to reach US$ 268.7 million by 2030, witnessing a CAGR of 2.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Adenomyosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adenomyosis Treatment.
Report Scope
The Adenomyosis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Adenomyosis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adenomyosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer AG
Ferring B.V
Johnson & Johnson
Novartis
Merck
Pfizer
Contura
Segment by Type
Anti-inflammatory Drugs
Hormone Medications
Other
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adenomyosis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adenomyosis Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Anti-inflammatory Drugs
1.2.3 Hormone Medications
1.2.4 Other
1.3 Market by Application
1.3.1 Global Adenomyosis Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adenomyosis Treatment Market Perspective (2019-2030)
2.2 Adenomyosis Treatment Growth Trends by Region
2.2.1 Global Adenomyosis Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Adenomyosis Treatment Historic Market Size by Region (2019-2024)
2.2.3 Adenomyosis Treatment Forecasted Market Size by Region (2025-2030)
2.3 Adenomyosis Treatment Market Dynamics
2.3.1 Adenomyosis Treatment Industry Trends
2.3.2 Adenomyosis Treatment Market Drivers
2.3.3 Adenomyosis Treatment Market Challenges
2.3.4 Adenomyosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adenomyosis Treatment Players by Revenue
3.1.1 Global Top Adenomyosis Treatment Players by Revenue (2019-2024)
3.1.2 Global Adenomyosis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Adenomyosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adenomyosis Treatment Revenue
3.4 Global Adenomyosis Treatment Market Concentration Ratio
3.4.1 Global Adenomyosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adenomyosis Treatment Revenue in 2023
3.5 Adenomyosis Treatment Key Players Head office and Area Served
3.6 Key Players Adenomyosis Treatment Product Solution and Service
3.7 Date of Enter into Adenomyosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adenomyosis Treatment Breakdown Data by Type
4.1 Global Adenomyosis Treatment Historic Market Size by Type (2019-2024)
4.2 Global Adenomyosis Treatment Forecasted Market Size by Type (2025-2030)
5 Adenomyosis Treatment Breakdown Data by Application
5.1 Global Adenomyosis Treatment Historic Market Size by Application (2019-2024)
5.2 Global Adenomyosis Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Adenomyosis Treatment Market Size (2019-2030)
6.2 North America Adenomyosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Adenomyosis Treatment Market Size by Country (2019-2024)
6.4 North America Adenomyosis Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adenomyosis Treatment Market Size (2019-2030)
7.2 Europe Adenomyosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Adenomyosis Treatment Market Size by Country (2019-2024)
7.4 Europe Adenomyosis Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adenomyosis Treatment Market Size (2019-2030)
8.2 Asia-Pacific Adenomyosis Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Adenomyosis Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Adenomyosis Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Adenomyosis Treatment Market Size (2019-2030)
9.2 Latin America Adenomyosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Adenomyosis Treatment Market Size by Country (2019-2024)
9.4 Latin America Adenomyosis Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adenomyosis Treatment Market Size (2019-2030)
10.2 Middle East & Africa Adenomyosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Adenomyosis Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Adenomyosis Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Detail
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Adenomyosis Treatment Introduction
11.1.4 Bayer AG Revenue in Adenomyosis Treatment Business (2019-2024)
11.1.5 Bayer AG Recent Development
11.2 Ferring B.V
11.2.1 Ferring B.V Company Detail
11.2.2 Ferring B.V Business Overview
11.2.3 Ferring B.V Adenomyosis Treatment Introduction
11.2.4 Ferring B.V Revenue in Adenomyosis Treatment Business (2019-2024)
11.2.5 Ferring B.V Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Adenomyosis Treatment Introduction
11.3.4 Johnson & Johnson Revenue in Adenomyosis Treatment Business (2019-2024)
11.3.5 Johnson & Johnson Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Adenomyosis Treatment Introduction
11.4.4 Novartis Revenue in Adenomyosis Treatment Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Adenomyosis Treatment Introduction
11.5.4 Merck Revenue in Adenomyosis Treatment Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Adenomyosis Treatment Introduction
11.6.4 Pfizer Revenue in Adenomyosis Treatment Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Contura
11.7.1 Contura Company Detail
11.7.2 Contura Business Overview
11.7.3 Contura Adenomyosis Treatment Introduction
11.7.4 Contura Revenue in Adenomyosis Treatment Business (2019-2024)
11.7.5 Contura Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Adenomyosis Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Anti-inflammatory Drugs
Table 3. Key Players of Hormone Medications
Table 4. Key Players of Other
Table 5. Global Adenomyosis Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Adenomyosis Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Adenomyosis Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Adenomyosis Treatment Market Share by Region (2019-2024)
Table 9. Global Adenomyosis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Adenomyosis Treatment Market Share by Region (2025-2030)
Table 11. Adenomyosis Treatment Market Trends
Table 12. Adenomyosis Treatment Market Drivers
Table 13. Adenomyosis Treatment Market Challenges
Table 14. Adenomyosis Treatment Market Restraints
Table 15. Global Adenomyosis Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Adenomyosis Treatment Market Share by Players (2019-2024)
Table 17. Global Top Adenomyosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adenomyosis Treatment as of 2023)
Table 18. Ranking of Global Top Adenomyosis Treatment Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Adenomyosis Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Adenomyosis Treatment Product Solution and Service
Table 22. Date of Enter into Adenomyosis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Adenomyosis Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Adenomyosis Treatment Revenue Market Share by Type (2019-2024)
Table 26. Global Adenomyosis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Adenomyosis Treatment Revenue Market Share by Type (2025-2030)
Table 28. Global Adenomyosis Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Adenomyosis Treatment Revenue Market Share by Application (2019-2024)
Table 30. Global Adenomyosis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Adenomyosis Treatment Revenue Market Share by Application (2025-2030)
Table 32. North America Adenomyosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Adenomyosis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Adenomyosis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Adenomyosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Adenomyosis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Adenomyosis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Adenomyosis Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Adenomyosis Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Adenomyosis Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Adenomyosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Adenomyosis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Adenomyosis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Adenomyosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Adenomyosis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Adenomyosis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 47. Bayer AG Company Detail
Table 48. Bayer AG Business Overview
Table 49. Bayer AG Adenomyosis Treatment Product
Table 50. Bayer AG Revenue in Adenomyosis Treatment Business (2019-2024) & (US$ Million)
Table 51. Bayer AG Recent Development
Table 52. Ferring B.V Company Detail
Table 53. Ferring B.V Business Overview
Table 54. Ferring B.V Adenomyosis Treatment Product
Table 55. Ferring B.V Revenue in Adenomyosis Treatment Business (2019-2024) & (US$ Million)
Table 56. Ferring B.V Recent Development
Table 57. Johnson & Johnson Company Detail
Table 58. Johnson & Johnson Business Overview
Table 59. Johnson & Johnson Adenomyosis Treatment Product
Table 60. Johnson & Johnson Revenue in Adenomyosis Treatment Business (2019-2024) & (US$ Million)
Table 61. Johnson & Johnson Recent Development
Table 62. Novartis Company Detail
Table 63. Novartis Business Overview
Table 64. Novartis Adenomyosis Treatment Product
Table 65. Novartis Revenue in Adenomyosis Treatment Business (2019-2024) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Merck Company Detail
Table 68. Merck Business Overview
Table 69. Merck Adenomyosis Treatment Product
Table 70. Merck Revenue in Adenomyosis Treatment Business (2019-2024) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Pfizer Company Detail
Table 73. Pfizer Business Overview
Table 74. Pfizer Adenomyosis Treatment Product
Table 75. Pfizer Revenue in Adenomyosis Treatment Business (2019-2024) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Contura Company Detail
Table 78. Contura Business Overview
Table 79. Contura Adenomyosis Treatment Product
Table 80. Contura Revenue in Adenomyosis Treatment Business (2019-2024) & (US$ Million)
Table 81. Contura Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adenomyosis Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Adenomyosis Treatment Market Share by Type: 2023 VS 2030
Figure 3. Anti-inflammatory Drugs Features
Figure 4. Hormone Medications Features
Figure 5. Other Features
Figure 6. Global Adenomyosis Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Adenomyosis Treatment Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Adenomyosis Treatment Report Years Considered
Figure 12. Global Adenomyosis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Adenomyosis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Adenomyosis Treatment Market Share by Region: 2023 VS 2030
Figure 15. Global Adenomyosis Treatment Market Share by Players in 2023
Figure 16. Global Top Adenomyosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adenomyosis Treatment as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Adenomyosis Treatment Revenue in 2023
Figure 18. North America Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Adenomyosis Treatment Market Share by Country (2019-2030)
Figure 20. United States Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Adenomyosis Treatment Market Share by Country (2019-2030)
Figure 24. Germany Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Adenomyosis Treatment Market Share by Region (2019-2030)
Figure 32. China Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Adenomyosis Treatment Market Share by Country (2019-2030)
Figure 40. Mexico Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Adenomyosis Treatment Market Share by Country (2019-2030)
Figure 44. Turkey Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Adenomyosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Bayer AG Revenue Growth Rate in Adenomyosis Treatment Business (2019-2024)
Figure 47. Ferring B.V Revenue Growth Rate in Adenomyosis Treatment Business (2019-2024)
Figure 48. Johnson & Johnson Revenue Growth Rate in Adenomyosis Treatment Business (2019-2024)
Figure 49. Novartis Revenue Growth Rate in Adenomyosis Treatment Business (2019-2024)
Figure 50. Merck Revenue Growth Rate in Adenomyosis Treatment Business (2019-2024)
Figure 51. Pfizer Revenue Growth Rate in Adenomyosis Treatment Business (2019-2024)
Figure 52. Contura Revenue Growth Rate in Adenomyosis Treatment Business (2019-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies